These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 10316799)

  • 1. Comparative Medicaid drug cost control experiences.
    Kennard LH; Platt WG
    Med Mark Media; 1979 Mar; 14(3):38, 40-3. PubMed ID: 10316799
    [No Abstract]   [Full Text] [Related]  

  • 2. Managing Medicaid drug expenditures.
    Sudovar SG; Rein SD
    J Health Hum Resour Adm; 1978 Nov; 1(2):200-30. PubMed ID: 10308767
    [No Abstract]   [Full Text] [Related]  

  • 3. Perspectives. Drug utilization review: apocalypse when?
    Ault A
    Faulkner Grays Med Health; 1992 Feb; 46(8):suppl 4 p.. PubMed ID: 10116064
    [No Abstract]   [Full Text] [Related]  

  • 4. Containing costs.
    Knapp DA
    Pharm Manage Comb Am J Pharm; 1979; 151(2):53-5. PubMed ID: 441144
    [No Abstract]   [Full Text] [Related]  

  • 5. Controlling pharmacy costs in the NC Medicaid program.
    Dobson LA
    N C Med J; 2003; 64(6):280-2. PubMed ID: 14983617
    [No Abstract]   [Full Text] [Related]  

  • 6. Using clinical evidence to manage pharmacy benefits: experiences of six states.
    Bergman D; Hoadley J; Kaye N; Crowley J; Hostetter M
    Issue Brief (Commonw Fund); 2006 Mar; (899):1-14. PubMed ID: 16562357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Your next move in managing drug costs.
    Heenan J
    Bus Health; 1995 Aug; 13(8):31-2, 36, 38. PubMed ID: 10153416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penny-wise ... pound-foolish? Caps on Medicaid drug payments offset by increased admissions to nursing homes.
    Am J Hosp Pharm; 1992 Feb; 49(2):256. PubMed ID: 1553990
    [No Abstract]   [Full Text] [Related]  

  • 9. Medicaid drug programs.
    McGovern J
    Nurs Homes; 1980; 29(1):30-1. PubMed ID: 10297673
    [No Abstract]   [Full Text] [Related]  

  • 10. Can health care costs be contained? Yes, says one third party fiscal intermediary.
    Kaplan SX
    Empl Benefits J; 1978; 3(4):10-3, 15. PubMed ID: 10294880
    [No Abstract]   [Full Text] [Related]  

  • 11. The elimination of selected drug products from the Michigan Medicaid formulary: a case study.
    Smith DM; McKercher PL
    Hosp Formul; 1984 May; 19(5):366-72. PubMed ID: 10299510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finding savings on the pharm.
    Splinter G; Nesser N
    J Okla State Med Assoc; 2011 May; 104(5):239. PubMed ID: 21977876
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of cost sharing on the demand for prescription drugs in Belgium.
    van Doorslaer E
    Acta Hosp; 1984; 24(3):69-81. PubMed ID: 10268808
    [No Abstract]   [Full Text] [Related]  

  • 14. Do drug copayments work?
    David J
    CMAJ; 1994 May; 150(9):1491-3. PubMed ID: 8168015
    [No Abstract]   [Full Text] [Related]  

  • 15. State Medicaid prescription drug expenditures for Medicare-Medicaid dual eligibles: estimates of Medicaid savings and federal expenditures resulting from expanded Medicare prescription coverage.
    Dale SB; Verdier JM
    Issue Brief (Commonw Fund); 2003 Apr; (627):1-12. PubMed ID: 12685428
    [No Abstract]   [Full Text] [Related]  

  • 16. States combat drug costs.
    Consum Rep; 2002 Dec; 67(12):8-9. PubMed ID: 12448442
    [No Abstract]   [Full Text] [Related]  

  • 17. Will HCFA jump NHI on outpatient drug coverage?
    Eastman M
    Am Pharm; 1978 Aug; 18(9):43. PubMed ID: 354364
    [No Abstract]   [Full Text] [Related]  

  • 18. Prescription drug benefits: promising solutions.
    Goff VV
    Issue Brief (Inst Health Care Costs Solut); 2002; 1(4):1-16. PubMed ID: 12825600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. As drug costs rise, health plans shift the burden.
    Capitation Manag Rep; 1997 Oct; 4(10):153-8. PubMed ID: 10175783
    [No Abstract]   [Full Text] [Related]  

  • 20. The utility of an organized drug data base in determining contributions to the quality and efficiency of Medicaid programs.
    Roden DR; Kennard LH
    Drug Inf J; 1975; 9(2-3):131-7. PubMed ID: 10297122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.